Lisata Therapeutics
LSTA
LSTA
24 hedge funds and large institutions have $1.8M invested in Lisata Therapeutics in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
17% less capital invested
Capital invested by funds: $2.17M → $1.8M (-$379K)
Holders
24
Holding in Top 10
–
Calls
$202K
Puts
–
Top Buyers
| 1 | +$37K | |
| 2 | +$18.2K | |
| 3 | +$9.6K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.86K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.43K |
Top Sellers
| 1 | -$32.3K | |
| 2 | -$2.63K | |
| 3 | -$1.28K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$609 |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
-$418 |